Cancer therapy related endocrine toxicities
Cancer-therapy related endocrine toxicities are increasing with the increasing use of immune-modulating and targeted anti-cancer treatments. In this recording we will discuss what an endocrinologist needs to know about these toxicities. Featuring presentations from Dr. L. Chaker, endocrinologist, and Dr. D.W. Dumoulin, pulmonary oncologist both from Erasmus MC, the Netherlands. The session will be chaired by Edward Visser, MTG8 co-chair.
▶︎
Advances in the diagnosis and management of Congenital Hypogonadotropic Hypogonadism CHH
▶︎
Cancer and metabolism
▶︎
Diagnosis and management of TSH resistance
▶︎
KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson’s Disease (2025)
▶︎
Use These 5 Food Hacks To Heal The Body & STARVE CANCER I Dr. William Li
▶︎
Dr. Arina Bingeliene - Pediatric Sleep Education Day - Saturday, May 23, 2026
▶︎
Ivermectin to Treat Cancer? Get the FACTS
▶︎
How Proctor’s texts in Karen Read lawsuit could free dangerous criminals
▶︎
Seeking Solutions in Secondary Stroke Prevention: Insights on Factor XIa Inhibition
▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎
EuRREB Rare disease research and the value of registries
▶︎
Cushing's disease and Cushing's syndrome
▶︎
Innovations in Pediatric HCM Care: The SCOUT-HCM Clinical Trial of Mavacamten
▶︎
ISHLT Recap Webinar
▶︎
Psilocybin in Depression: Insights From Contemporary Clinical Trials
▶︎
Congenital combined pituitary hormone deficiency in Europe
▶︎
MoonBounce: Internals of the 3rd publicly known UEFI firmware implant | Mark Lechtik | hardwear.io
▶︎
Recognizing Pediatric Hereditary Hematologic Malignancies (June 2026)
▶︎
ABC Educational Webinar: Understanding Biomarkers and Their Impact on Brain Health
▶︎